Omali Pitiyarachchi

2PUBLICATIONS
2CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Mar 21, 2025
Trastuzumab deruxtecan in HER2 overexpressing non-small cell lung cancer (NSCLC).

Omali Pitiyarachchi, Aaron C Tan

|Jun 19, 2022
Durvalumab and multimodality therapy in a patient with multiple recurrent and unresectable cutaneous squamous cell carcinoma.

Omali Pitiyarachchi, Wenchang Wong, Melvin Chin

Pageof 1